tradingkey.logo
tradingkey.logo
Pesquisar

Amneal Pharmaceuticals Inc

AMRX
Adicionar à lista de desejos
17.310USD
+0.020+0.12%
Fechamento 06/30, 16:00ETCotações atrasadas em 15 min
5.52BValor de mercado
44.64P/L TTM

Mais detalhes de Amneal Pharmaceuticals Inc Empresa

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Informações de Amneal Pharmaceuticals Inc

Código da empresaAMRX
Nome da EmpresaAmneal Pharmaceuticals Inc
Data de listagemNov 18, 2009
CEOPatel (Chintu)
Número de funcionários8100
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 18
Endereço400 Crossing Boulevard, 3rd Floor
CidadeBRIDGEWATER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal08807
Telefone19089473120
Sitehttps://amneal.com/
Código da empresaAMRX
Data de listagemNov 18, 2009
CEOPatel (Chintu)

Executivos da empresa Amneal Pharmaceuticals Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.64M
+2.12%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
449.43K
-38.37%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
399.79K
+52.12%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
320.80K
+10.85%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Amneal Pharmaceuticals Inc?

Os cinco principais acionistas de Amneal Pharmaceuticals Inc são: Mr. Chintu Patel

Quantas instituições possuem ações da Amneal Pharmaceuticals Inc (AMRX)?

Em 2026Q1, 521 instituições possuíam ações da Amneal Pharmaceuticals Inc, com valor de mercado aproximado de 161.64M, representando 50.67% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -25718515.00.

Qual é a maior fonte de receita da Amneal Pharmaceuticals Inc?

Em 2026Q1, o segmento de negócios Oral solid gerou a maior receita para Amneal Pharmaceuticals Inc, totalizando 726.38M e representando 24.06% da receita total.
KeyAI